Document Detail


Switching from biphasic human insulin 30 to biphasic insulin aspart 30 in type 2 diabetes is associated with improved glycaemic control and a positive safety profile: Results from the A(1)chieve study.
MedLine Citation:
PMID:  23217267     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Aims: This A1chieve® study subgroup analysis examined clinical safety and effectiveness of biphasic insulin aspart 30 (BIAsp30) ±OGLDs in 6323 individuals with T2D, switching from biphasic human insulin 30 (BHI30) ±OGLDs. Methods: A1chieve was a 24-week, international, prospective, observational, multi-centre, open-label study in individuals with T2D starting treatment with BIAsp30, insulin detemir or insulin aspart as part of routine clinical care. Results: Mean baseline (SD) dose BHI was 0.56 (0.25) IU/kg. BIAsp30 was initiated at 0.57 (0.25) U/kg; the daily dose was 0.62 (0.28)U/kg by Week 24. Switching from BHI30 to BIAsp30 was associated with significant mean reduction in HbA1c of 1.7% [-18 mmol/mol] (1.6) from a baseline of 9.1% [76 mmol/mol] (p<0.001); FPG and PPG were also significantly reduced (p<0.001). Major hypoglycaemic episodes decreased from 0.69 events/patient/year at baseline to 0.03 events/patient/year at Week 24. Minor hypoglycaemia decreased from 5.31 to 2.04 events/patient/year from baseline to study-end. Five serious adverse drug reactions (hypoglycaemia) were reported by five individuals (0.1%). Mean bodyweight increased by 0.1 (3.3)kg from baseline to 24 weeks. Improved self-reported quality of life was observed. Conclusion: Switching from BHI30 to BIAsp30 in individuals with T2D is associated with improvement in glycaemic control and reduced rates of hypoglycaemia, without tolerability or safety issues. Clinical trial registration: Clinicaltrials.gov, NCT00869908.
Authors:
Nabil K El Naggar; Pradana Soewondo; Mohammad E Khamseh; Jian-Wen Chen; Jihad Haddad
Related Documents :
24525867 - A review of anti-vegf agents for proliferative diabetic retinopathy.
23952467 - Choice of early treatment regimen and impact on β-cell preservation in type 2 diabetes.
24379917 - Type 2 diabetes mellitus in children and adolescents.
8163287 - Association of phenylthiocarbamide taste sensitivity with diabetes mellitus in bangladesh.
8138067 - The squatting test. a useful tool to assess both parasympathetic and sympathetic involv...
9032097 - Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cho...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Diabetes research and clinical practice     Volume:  98     ISSN:  1872-8227     ISO Abbreviation:  Diabetes Res. Clin. Pract.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8508335     Medline TA:  Diabetes Res Clin Pract     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  408-13     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Hai Al Jamea Hospital, Jeddah, Jeddah 21433, The Kingdom of Saudi Arabia. Electronic address: nelnaggar@yahoo.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Meta-analysis identified the TNFA -308G>A promoter polymorphism as a risk factor for disease severit...
Next Document:  Double J stent of frontal sinus outflow tract in revision frontal sinus surgery.